Harnessing Deep Learning Methods for Voltage-Gated Ion Channel Drug Discovery
Physiology · 01.01.2025 · 40 (1) · 67-87
DOI: 10.1152/physiol.00029.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiology, erschienen am 01.01.2025. Verfasst von Diego Lopez-Mateos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Membrane Biology, University of California School of Medicine, Davis, California, United States. Hauptthemen laut MEDLINE: Deep Learning, Drug Discovery. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of General Medical Sciences (NIGMS), NHLBI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Voltage-gated ion channels (VGICs) are pivotal in regulating electrical activity in excitable cells and are critical pharmaceutical targets for treating many diseases including cardiac arrhythmia and neuropathic pain. Despite their significance, challenges such as achieving target selectivity persist in VGIC drug development. Recent progress in deep learning, particularly diffusion models, has enabled the computational design of protein binders for any clinically relevant protein based solely on its structure. These developments coincide with a surge in experimental structural data for VGICs, providing a rich foundation for computational design efforts. This review explores the recent advancements in computational protein design using deep learning and diffusion methods, focusing on their application in designing protein binders to modulate VGIC activity. We discuss the potential use of these methods to computationally design protein binders targeting different regions of VGICs, including the pore domain, voltage-sensing domains, and interface with auxiliary subunits. We provide a comprehensive overview of the different design scenarios, discuss key structural considerations, and address the practical challenges in developing VGIC-targeting protein binders. By exploring these innovative computational methods, we aim to provide a framework for developing novel strategies that could significantly advance VGIC pharmacology and lead to the discovery of effective and safe therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Membrane Biology, University of California School of Medicine, Davis, California, United States.
- Biophysics Graduate Group, University of California School of Medicine, Davis, California, United States.
- Department of Anesthesiology and Pain Medicine, University of California School of Medicine, Davis, California, United States.
ORCID-Profile: Diego Lopez-Mateos, Brandon John Harris, Vladimir Yarov-Yarovoy
Förderung
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- NHLBI NIH HHS
- NINDS NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- NIGMS NIH HHS
- Fulbright U.S. Student Program
Zitieren
APA
Lopez-Mateos, D., Harris, B. J., Hernández-González, A., Narang, K., & Yarov-Yarovoy, V. (2025). Harnessing Deep Learning Methods for Voltage-Gated Ion Channel Drug Discovery. Physiology, 40(1), 67-87. https://doi.org/10.1152/physiol.00029.2024
Vancouver
Lopez-Mateos D, Harris BJ, Hernández-González A, Narang K, Yarov-Yarovoy V. Harnessing Deep Learning Methods for Voltage-Gated Ion Channel Drug Discovery. Physiology. 2025;40(1):67-87. doi:10.1152/physiol.00029.2024
BibTeX
@article{LopezMateos2025,
author = {Lopez-Mateos, Diego and Harris, Brandon John and Hernández-González, Adriana and Narang, Kush and Yarov-Yarovoy, Vladimir},
title = {Harnessing Deep Learning Methods for Voltage-Gated Ion Channel Drug Discovery},
journal = {Physiology},
year = {2025},
volume = {40},
number = {1},
pages = {67--87},
doi = {10.1152/physiol.00029.2024}
}
EUVIMED